Cite

HARVARD Citation

    Shi, A. et al. (n.d.). 98P First-line atezolizumab/durvalumab plus platinum-etoposide combined with radiotherapy in extensive-stage small cell lung cancer. Immuno-oncology technology. p. . [Online]. 
  
Back to record